Related Experiment Video

Updated: Apr 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic

Fotios Barkas1, Haralampos Milionis, Michael S Kostapanos

  • 1Department of Internal Medicine, School of Medicine, University of Ioannina , Ioannina , Greece.

Current Medical Research and Opinion
|November 25, 2014
PubMed

Insights

Recent guidelines for lowering cholesterol may undertreat high-risk patients. Adding ezetimibe to statins significantly improves low-density lipoprotein cholesterol (LDL-C) goal achievement in clinical practice.

Area of Science:

  • Cardiology
  • Clinical Pharmacy
  • Public Health

Background:

  • Lipid-lowering treatment goals are crucial for cardiovascular risk management.
  • Recent American College of Cardiology/American Heart Association (ACC/AHA) guidelines provide updated recommendations.
  • Data on the attainment of these goals in clinical practice are limited.

Purpose of the Study:

  • To evaluate the applicability of the 2013 ACC/AHA lipid-lowering guidelines.
  • To assess treatment goal attainment in an Outpatient University Hospital Lipid Clinic.
  • To compare guideline applicability with European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) recommendations.

Main Methods:

  • Retrospective observational study of 1000 adult hyperlipidemia patients (1999-2013).
  • Follow-up duration of at least 3 years.
  • Analysis of low-density lipoprotein cholesterol (LDL-C) target achievement with statin monotherapy versus statin plus ezetimibe.

Main Results:

  • Statin monotherapy achieved ESC/EAS LDL-C targets in 21-62% of patients across risk groups.
  • Only 47% of patients on high-intensity statins met the ACC/AHA ≥50% LDL-C reduction target.
  • Adding ezetimibe increased LDL-C target attainment to 76% (p<0.05) and improved ESC/EAS goal achievement.

Conclusions:

  • The ACC/AHA guidelines may lead to undertreatment of high-risk patients due to suboptimal statin response.
  • Combination therapy with ezetimibe significantly enhances LDL-C goal attainment.
  • Ezetimibe addition improves both ESC/EAS target achievement and ACC/AHA-suggested LDL-C reduction rates.
Abstract

Keywords:
ACC/AHAESC/EASEzetimibeGuidelinesLipid lowering treatmentStatinsTreatment goals

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

818
High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

558

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
634
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
461
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
503